Application of quantitative estimates of fecal hemoglobin concentration for risk prediction of colorectal neoplasia

World Journal of Gastroenterology

Volumn 19, Issue 45, 2013, Pages 8366-8372

  Liao, Chao Sheng ^b   Lin, Yu Min ^b   Chang, Hung Chuen ^a   Chen, Yu Hung ^a   Chong, Lee Won ^a   Chen, Chun Hao ^a   Lin, Yueh Shih ^a   Yang, Kuo Ching ^a   Shih, Chia Hui ^c  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Colorectal cancer; Fecal immunochemical test; Performance; Risk prediction; Screening

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER SCREENING; CANCER STAGING; COLONOSCOPY; COLORECTAL TUMOR; DISEASE ASSOCIATION; FECAL IMMUNOCHEMICAL TEST; FECES ANALYSIS; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIPLE LINEAR REGRESSION ANALYSIS; QUALITY CONTROL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT;

COLORECTAL CANCER; FECAL IMMUNOCHEMICAL TEST; PERFORMANCE; RISK PREDICTION; SCREENING;

ADENOMA; BIOPSY; COLONOSCOPY; COLORECTAL NEOPLASMS; FALSE POSITIVE REACTIONS; FECES; FEMALE; HEMOGLOBINS; HUMANS; IMMUNOHISTOCHEMISTRY; LINEAR MODELS; MALE; MIDDLE AGED; NEOPLASM GRADING; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84889572787     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i45.8366     Document Type: Article

References (28)

1. Chiang CJ, Chen YC, Chen CJ, You SL, Lai MS. Cancer trends in Taiwan. Jpn J Clin Oncol 2010; 40: 897-904 [PMID: 20495192 DOI: 10.1093/jjco/hyq057]
2. Scholefield JH, Moss SM, Mangham CM, Whynes DK, Hardcastle JD. Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up. Gut 2012; 61: 1036-1040 [PMID: 22052062 DOI: 10.1136/ gutjnl-2011-300774]
3. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993; 328: 1365-1371 [PMID: 8474513]
4. Kronborg O, Fenger C, Olsen J, Jørgensen OD, Søndergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 348: 1467-1471 [PMID: 8942774]
5. Duffy MJ, van Rossum LG, van Turenhout ST, Malminiemi O, Sturgeon C, Lamerz R, Nicolini A, Haglund C, Holubec L, Fraser CG, Halloran SP. Use of faecal markers in screening for colorectal neoplasia: a European group on tumor markers position paper. Int J Cancer 2011; 128: 3-11 [PMID: 20824704 DOI: 10.1002/ijc.25654]
6. Fraser CG, Mathew CM, McKay K, Carey FA, Steele RJ. Automated immunochemical quantitation of haemoglobin in faeces collected on cards for screening for colorectal cancer. Gut 2008; 57: 1256-1260 [PMID: 18467371 DOI: 10.1136/ gut.2008.153494]
7. Fraser CG. Screening for colorectal neoplasia with faecal tests. Lancet Oncol 2011; 12: 516-517 [PMID: 21592860 DOI: 10.1016/S1470-2045(11)70106-1]
8. Omata F, Shintani A, Isozaki M, Masuda K, Fujita Y, Fukui T. Diagnostic performance of quantitative fecal immunochemical test and multivariate prediction model for colorectal neoplasms in asymptomatic individuals. Eur J Gastroenterol Hepatol 2011; 23: 1036-1041 [PMID: 21897207 DOI: 10.1097/ MEG.0b013e32834a2882]
9. Chen LS, Yen AM, Chiu SY, Liao CS, Chen HH. Baseline faecal occult blood concentration as a predictor of incident colorectal neoplasia: longitudinal follow-up of a Taiwanese population-based colorectal cancer screening cohort. Lancet Oncol 2011; 12: 551-558 [PMID: 21592859 DOI: 10.1016/ S1470-2045(11)70101-2]
10. Maxwell AE, Crespi CM, Antonio CM, Lu P. Explaining disparities in colorectal cancer screening among five Asian ethnic groups: a population-based study in California. BMC Cancer 2010; 10: 214 [PMID: 20482868 DOI: 10.1186/1471-24 07-10-214]
11. Damery S, Clifford S, Wilson S. Colorectal cancer screening using the faecal occult blood test (FOBt): a survey of GP attitudes and practices in the UK. BMC Fam Pract 2010; 11: 20 [PMID: 20214769 DOI: 10.1186/1471-2296-11-20]
12. Wong MC, Lam AT, Li DK, Lau JT, Griffiths SM, Sung JJ. Factors associated with practice of colorectal cancer screening among primary care physicians in a Chinese population: a cross-sectional study. Cancer Epidemiol 2009; 33: 201-206 [PMID: 19709943 DOI: 10.1016/j.canep.2009.07.008]
13. Yeoh KG, Ho KY, Chiu HM, Zhu F, Ching JY, Wu DC, Matsuda T, Byeon JS, Lee SK, Goh KL, Sollano J, Rerknimitr R, Leong R, Tsoi K, Lin JT, Sung JJ. The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects. Gut 2011; 60: 1236-1241 [PMID: 21402615 DOI: 10.1136/gut.2010.221168]
14. Fraser CG, Allison JE, Halloran SP, Young GP. A proposal to standardize reporting units for fecal immunochemical tests for hemoglobin. J Natl Cancer Inst 2012; 104: 810-814 [PMID: 22472305 DOI: 10.1093/jnci/djs190]
15. Allison JE, Fraser CG, Halloran SP, Young GP. Comparing fecal immunochemical tests: improved standardization is needed. Gastroenterology 2012; 142: 422-424 [PMID: 22281273 DOI: 10.1053/j.gastro.2012.01.015]
16. Lee TJ, Rutter MD, Blanks RG, Moss SM, Goddard AF, Chilton A, Nickerson C, McNally RJ, Patnick J, Rees CJ. Colonoscopy quality measures: experience from the NHS Bowel Cancer Screening Programme. Gut 2012; 61: 1050-1057 [PMID: 21940723 DOI: 10.1136/gutjnl-2011-300651]
17. Yang H, Ge Z, Dai J, Li X, Gao Y. Effectiveness of the immunofecal occult blood test for colorectal cancer screening in a large population. Dig Dis Sci 2011; 56: 203-207 [PMID: 20458621 DOI: 10.1007/s10620-010-1264-8]
18. Pox C. Colon cancer screening: which non-invasive filter tests? Dig Dis 2011; 29 Suppl 1: 56-59 [PMID: 22104755 DOI: 10.1159/000331127]
19. Ekelund G, Manjer J, Zackrisson S. Population-based screening for colorectal cancer with faecal occult blood test--do we really have enough evidence? Int J Colorectal Dis 2010; 25: 1269-1275 [PMID: 20676659 DOI: 10.1007/ s00384-010-1027-1]
20. Lindqvist M. [The Christian viewpoint of therapy in human development processes]. Sairaanh Vuosik 1978; 15: 253-269 [PMID: 254390]
21. MacDonald AJ, McEwan H, McCabe M, Macdonald A. Age at death of patients with colorectal cancer and the effect of lead-time bias on survival in elective vs emergency surgery. Colorectal Dis 2011; 13: 519-525 [PMID: 20041912 DOI: 10.1111/j.1463-1318.2009.02183.x]
22. Levi Z, Rozen P, Hazazi R, Vilkin A, Waked A, Maoz E, Birkenfeld S, Leshno M, Niv Y. A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med 2007; 146: 244-255 [PMID: 17310048]
23. Ciatto S, Martinelli F, Castiglione G, Mantellini P, Rubeca T, Grazzini G, Bonanomi AG, Confortini M, Zappa M. Association of FOBT-assessed faecal Hb content with colonic lesions detected in the Florence screening programme. Br J Cancer 2007; 96: 218-221 [PMID: 17211476]
24. McDonald PJ, Strachan JA, Digby J, Steele RJ, Fraser CG. Faecal haemoglobin concentrations by gender and age: implications for population-based screening for colorectal cancer. Clin Chem Lab Med 2012; 50: 935-940 [PMID: 22149740 DOI: 10.1515/CCLM.2011.815]
25. McLean MH, Murray GI, Stewart KN, Norrie G, Mayer C, Hold GL, Thomson J, Fyfe N, Hope M, Mowat NA, Drew JE, El-Omar EM. The inflammatory microenvironment in colorectal neoplasia. PLoS One 2011; 6: e15366 [PMID: 21249124 DOI: 10.1371/journal.pone.0015366]
26. Potente M, Gerhardt H, Carmeliet P. Basic and therapeutic aspects of angiogenesis. Cell 2011; 146: 873-887 [PMID: 21925313 DOI: 10.1016/j.cell.2011.08.039]
27. Yabroff KR, Klabunde CN, Yuan G, McNeel TS, Brown ML, Casciotti D, Buckman DW, Taplin S. Are physicians' recommendations for colorectal cancer screening guideline-consistent? J Gen Intern Med 2011; 26: 177-184 [PMID: 20949328 DOI: 10.1007/s11606-010-1516-5]
28. van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, Jansen JB, Verbeek AL, Dekker E. Cutoff value determines the performance of a semi-quantitative immunochemical faecal occult blood test in a colorectal cancer screening programme. Br J Cancer 2009; 101: 1274-1281 [PMID: 19755997 DOI: 10.1038/sj.bjc.6605326]